anaesthesia, Perioperative medicine & pain management

---

NIHR Portfolio Studies - Open to recruitment:

PQIP: Perioperative Quality Improvement Programme: Patient Study
Principal Investigator: Prof. Anil Hormis
​Sponsor: University College London
The Perioperative Quality Improvement Programme (PQIP) measures complications, mortality and patient reported outcome from major non-cardiac surgery. The ambition is to deliver real benefits to patients by supporting clinicians in using data to improve patient outcomes across the UK, reducing variation in processes of care and supporting implementation of best practice. 
Open to Associate PI scheme

---

 

---

SINFONIA
Principal Investigator: Prof. Anil Hormis
​Sponsor: Belfast Health and Social Care Trust
This study aims to determine whether sugammadex is superior to neostigmine after elective or emergency abdominal surgery or non-cardiac thoracic surgery.

---

LOLIPOP
Principal Investigator: Prof. Anil Hormis
Sponsor: Monash University, Melbourne, Australia and University Hospital Southampton NHS Foundation Trust, UK
This study will evaluate the effectiveness of lidocaine infusions commenced during surgery and extending up to 24 hours postoperatively, on the incidence of moderate or severe chronic post-surgical pain detected one year following surgery in female patients undergoing elective breast surgery.

nihr portfolio studies - in set up:

OSIRIS
Principal Investigator: Professor Anil Hormis
Sponsor: Queen Mary University of London
This study will evaluate the clinical effectiveness of a decision support intervention in a cluster randomised trial to improve shared decision making for high-risk surgical patients and their doctors.

POP-I
Principal Investigator: Dr Nandkishor Athavale
Sponsor: University of Nottingham
The POP-I trial aims to recruit patients who develop anaemia after either hip fracture surgery or after emergency abdominal surgery. Participants who give consent will be assigned randomly into one of three study groups:  
1: Usual hospital care.
2: Usual hospital care + Iron by IV infusion.
3: Usual hospital care + Iron by IV infusion + an ESA injection.